A Molecular Therapy journal piece covers immunomodulatory proteins and peptides from helminths and their potential use as treatments for inflammatory disease.
Recap by typeshit. Post by Molecular Therapy Family of Journals on X.
Researchers are starting to explain the shifts in libido some GLP-1 users report. The full story covers what scientists have found so far.
Bikman says the added glucagon receptor push raises energy use and liver fat burning, and points to 24.2% weight loss on 12 mg in phase 2.
9:08
Archibald takes on a common question about low retatrutide doses and the drug's glucagon action. His view, not settled science, and retatrutide is still unapproved.
A report says an Eli Lilly drug helped protect muscle mass when combined with Novo's Wegovy, addressing a common worry about lean mass loss.
Wellness influencers tout peptides for muscle and longevity, but experts quoted by Moneywise say not all of them have the science to back it up.
A physician says the board brought together endocrinologists, internists, gastroenterologists, cardiologists and gynecologists, each with a different view.
Loading…